Prestige Consumer (NYSE: PBH) CFO gets stock awards, tax shares withheld

Q: What did PBH executive Christine Sacco report in this Form 4?

Christine Sacco, CFO & COO of Prestige Consumer Healthcare (PBH) , reported equity compensation activity. She received vested performance stock units and a new restricted stock grant, and had shares withheld to cover taxes, resulting in updated direct share ownership.

Q: How many PBH shares did Christine Sacco acquire through performance stock units?

Christine Sacco acquired 11,976 shares of Prestige Consumer Healthcare common stock through settlement of performance stock units granted on May 5, 2023. These PSUs vested on May 4, 2026 based on achieving goals tied to per share growth .

Q: What restricted stock award did PBH grant to Christine Sacco?

Christine Sacco received a 7,008‑share restricted stock award in Prestige Consumer Healthcare common stock. According to the filing, this Restricted Stock vests in three equal installments of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029.

Q: Were any PBH shares sold by Christine Sacco in the open market?

The Form 4 shows 3,434 shares were disposed of with code F at $55.31 per share, described as payment of tax liability by delivering securities. This represents tax withholding, not an open‑market sale transaction.

Q: What performance condition was tied to Christine Sacco’s PBH PSUs?

The performance stock units that settled into 11,976 shares for Christine Sacco vested on May 4, 2026. The filing states vesting depended on achievement of goals related to per share growth , linking her award to company performance metrics.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. reported that CFO & COO Christine Sacco received equity compensation and related tax withholding transactions in company stock. She acquired 11,976 shares of common stock upon settlement of performance stock units granted on May 5, 2023, which vested on May 4, 2026 based on per share growth goals. She also received a 7,008‑share restricted stock award that vests in three equal installments of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029. To cover tax obligations, 3,434 shares were withheld at $55.31 per share. After these transactions, she directly holds 61,918 shares of Prestige Consumer Healthcare common stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Sacco Christine

Role CFO & COO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	7,008	$0.00	--
Tax Withholding	Common Stock, par value $0.01 per share	3,434	$55.31	$190K
Grant/Award	Common Stock, par value $0.01 per share	11,976	$0.00	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 65,352 shares (Direct, null)

Footnotes (1)

Reflects the settlement of performance stock units ("PSUs") granted to the reporting person on May 5, 2023, which PSUs vested on May 4, 2026 based on achievement of goals related to per share growth. The Restricted Stock vests in three equal installments each of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029.

Key Figures

PSU settlement shares: 11,976 shares Restricted stock grant: 7,008 shares Tax withholding shares: 3,434 shares +2 more

5 metrics

PSU settlement shares 11,976 shares Performance stock units vested on May 4, 2026

Restricted stock grant 7,008 shares Restricted Stock award on May 4, 2026

Tax withholding shares 3,434 shares Shares withheld at $55.31 per share for taxes

Withholding price $55.31 per share Price used for F-code tax-withholding disposition

Post-transaction holdings 61,918 shares Direct common stock owned after reported transactions

Key Terms

performance stock units, PSUs, Restricted Stock, per share growth, +1 more

5 terms

performance stock units financial

"Reflects the settlement of performance stock units ("PSUs") granted to the reporting person"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

PSUs financial

"performance stock units ("PSUs") granted to the reporting person on May 5, 2023"

PSUs are company shares promised to employees or executives that only become actual stock if the business hits specific performance targets over a set period. For investors, PSUs matter because they link pay to measurable outcomes — similar to a conditional bonus that converts into ownership — which can influence management decisions, dilution of shares, and signals about confidence in future results.

Restricted Stock financial

"The Restricted Stock vests in three equal installments each of 3,992 shares"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax-withholding disposition financial

"Payment of exercise price or tax liability by delivering securities"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

05/06/2026 - 05:17 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sacco Christine

(Last)

(First)

(Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN

NEW YORK

10591

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CFO & COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	05/04/2026		A		7,008⁽¹⁾	A	$0	65,352	D
Common Stock, par value $0.01 per share	05/04/2026		F		3,434	D	$55.31	61,918	D
Common Stock, par value $0.01 per share	05/04/2026		A⁽²⁾		11,976	A	$0	73,894	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects the settlement of performance stock units ("PSUs") granted to the reporting person on May 5, 2023, which PSUs vested on May 4, 2026 based on achievement of goals related to per share growth.

2. The Restricted Stock vests in three equal installments each of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029.

	/s/ Christine Sacco by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 8, 2017 on file with the Commission	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did PBH executive Christine Sacco report in this Form 4?

Christine Sacco, CFO & COO of Prestige Consumer Healthcare (PBH), reported equity compensation activity. She received vested performance stock units and a new restricted stock grant, and had shares withheld to cover taxes, resulting in updated direct share ownership.

How many PBH shares did Christine Sacco acquire through performance stock units?

Christine Sacco acquired 11,976 shares of Prestige Consumer Healthcare common stock through settlement of performance stock units granted on May 5, 2023. These PSUs vested on May 4, 2026 based on achieving goals tied to per share growth.

What restricted stock award did PBH grant to Christine Sacco?

Christine Sacco received a 7,008‑share restricted stock award in Prestige Consumer Healthcare common stock. According to the filing, this Restricted Stock vests in three equal installments of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029.

Were any PBH shares sold by Christine Sacco in the open market?

The Form 4 shows 3,434 shares were disposed of with code F at $55.31 per share, described as payment of tax liability by delivering securities. This represents tax withholding, not an open‑market sale transaction.

How many PBH shares does Christine Sacco own after these transactions?

Following the reported equity grant, PSU settlement, and tax withholding, Christine Sacco directly holds 61,918 shares of Prestige Consumer Healthcare common stock. This figure reflects her updated direct ownership position after all Form 4 transactions.

What performance condition was tied to Christine Sacco’s PBH PSUs?

The performance stock units that settled into 11,976 shares for Christine Sacco vested on May 4, 2026. The filing states vesting depended on achievement of goals related to per share growth, linking her award to company performance metrics.